Research article · 2020
Research articlePublished 2018
Adjuvant Chemotherapy For Pancreatic Cancer - Can It Really Be Recommended? Conclusions From The Reassessment Of ESPAC-1 Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Context According to the current guidelines, adjuvant chemotherapy is an integral part of the treatment concept for advanced pancreatic cancer. Randomised controlled studies showed that postoperative chemotherapy prolongs survival and reduces the recurrence rate. Objective The aim of our project was to analyse the validity of the most important study on this topic (ESPAC-1) by evaluating the data published in four publications (study design 1993, trial progress report 1997, interim results 2001, final results 2004). Design Our detailed analysis of the validity of the ESPAC-1 trial included the study design, recruitment period, patient selection, randomisation, changes in the protocol, participating institutions, homogeneity of subjects, surgical quality, statistical methods and interpretation of results. Results We identified several shortcomings in the patient selection, participating clinics, randomisation, changes in the protocol, surgical quality, statistics and evaluation of the results. Conclusion Although all analyzed papers concerned the same trial, the detailed evaluation revealed many inconsistencies. We therefore conclude that the validity of the ESPAC-1 trial is not sufficient to make a recommendation for adjuvant chemotherapy for advanced pancreatic cancer.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2015
Results of Adjuvant Surgery after Combination Chemotherapy for Pancreatic Carcinoma with Multiple Liver Metastases
Conference abstract · 6 Dec 2018
Adjuvant chemotherapy after neoadjuvant chemoradiation in esophageal cancer: A propensity score matched analysis
Editorial · 17 Apr 2017
CDX2 - A Predictive Biomarker in Stage II Colon Cancer for Adjuvant Chemotherapy?
Article · 2006
Radiotherapy and Chemotherapy in Pancreatic Cancer. Topical Issues and Future Perspectives
More from this journal
The newest in Journal of the Pancreas.
Article · 13 Nov 2026
Probable Acute Pancreatitis Following Excessive Oral Intake of a Commercial Rhopalurus junceus (Blue Scorpion) Extract: A Case Report
Article · 25 Jun 2026
Comparative outcomes of Open and Laparoscopic drainage in Walled off Pancreatic Necrosis
Article · 24 Feb 2026
Xanthogranulomatous Pancreatitis Showing Overlapping
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of the Pancreas
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Katrin Bauer”
- BylineArticles whose byline prints “Christel Weiss”
- BylineArticles whose byline prints “Doris Henne-Bruns”
